Myelodysplastic Syndrome

Showing 1 - 25 of 441

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Myelodysplastic Syndrome, Recurrent Myelodysplastic Syndrome, Refractory Myelodysplastic Syndrome Trial in Philadelphia

Not yet recruiting
  • Myelodysplastic Syndrome
  • +2 more
  • Navitoclax
  • +6 more
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Sep 29, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial (Azacitidine, Biospecimen Collection, Bone Marrow Aspiration)

Not yet recruiting
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • (no location specified)
Sep 29, 2022

Acute Erythroid Leukemia, Acute Lymphoblastic Leukemia, Acute Megakaryoblastic Leukemia Trial in United States (drug, radiation,

Recruiting
  • Acute Erythroid Leukemia
  • +10 more
  • San Francisco, California
  • +4 more
Aug 22, 2022

Myelodysplastic Syndrome, Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Bethesda, Minneapolis (biological, drug,

Recruiting
  • Myelodysplastic Syndrome
  • +4 more
  • Rituximab
  • +6 more
  • Bethesda, Maryland
  • +1 more
Aug 20, 2022

Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine, Quizartinib,

Recruiting
  • Acute Myeloid Leukemia
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Myelodysplastic Syndrome Trial in Worldwide (Lenalidomide)

Completed
  • Myelodysplastic Syndrome
  • Centre City, New Jersey
  • +148 more
Aug 18, 2022

Acute Myeloid Leukemia, Acute Myeloid Leukemia With Multilineage Dysplasia, Chronic Myelomonocytic Leukemia Trial in Chapel

Recruiting
  • Acute Myeloid Leukemia
  • +5 more
  • Chapel Hill, North Carolina
  • +1 more
Aug 2, 2022

Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in Houston (Decitabine and Cedazuridine, Venetoclax)

Recruiting
  • Chronic Myelomonocytic Leukemia
  • Myelodysplastic Syndrome
  • Houston, Texas
    M D Anderson Cancer Center
Jul 18, 2022

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome Trial in United States (PRT1419)

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Orange City, Florida
    • +6 more
    Jul 13, 2022

    Acute Leukemia, Acute Lymphocytic Leukemia, Acute Myelogenic Leukemia Trial (Haploidentical hematopoietic cell transplantation

    Not yet recruiting
    • Acute Leukemia
    • +4 more
    • Haploidentical hematopoietic cell transplantation (haploHCT)
    • matched unrelated donor hematopoietic cell transplantation (MUD-HCT)
    • (no location specified)
    Jul 13, 2022

    Myelodysplastic Syndrome, Allogeneic Hematopoietic Stem Cell Transplantation, Conditioning Trial in Guangzhou (Granulocyte

    Recruiting
    • Myelodysplastic Syndrome
    • +2 more
    • Granulocyte Colony-Stimulating Factor(G-CSF)
    • +5 more
    • Guangzhou, Guangdong, China
      Department of Hematology,Nanfang Hospital, Southern Medical Univ
    Jul 11, 2022

    Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Duarte (drug, procedure, other)

    Not yet recruiting
    • Acute Lymphoblastic Leukemia
    • +6 more
    • Duarte, California
      City of Hope Medical Center
    Jul 6, 2022

    Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory, Myelodysplastic Syndrome Trial in Zhengzhou (6MW3211

    Not yet recruiting
    • Acute Myeloid Leukemia, in Relapse
    • +2 more
    • 6MW3211 injection with Intravenous Infusion
    • Zhengzhou, Henan, China
      Henan Cancer Hospital
    Jul 2, 2022

    Chronic Myelomonocytic Leukemia, Myelodysplastic Syndrome, Myeloproliferative Tumor Trial in Houston (Azacitidine, Quizartinib)

    Recruiting
    • Chronic Myelomonocytic Leukemia
    • +5 more
    • Houston, Texas
      M D Anderson Cancer Center
    May 23, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

    Terminated
    • Acute Myeloid Leukemia
    • +2 more
    • ATIR101
    • +3 more
    • Duarte, California
    • +41 more
    Apr 28, 2022

    Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Chronic Myelogenous Leukemia, BCR-ABL1 Positive Trial in Seattle

    Recruiting
    • Acute Biphenotypic Leukemia
    • +5 more
    • Dilanubicel
    • +6 more
    • Seattle, Washington
      Fred Hutch/University of Washington Cancer Consortium
    May 11, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • SY-1425 (tamibarotene)
    • +2 more
    • Hartford, Connecticut
    • +25 more
    May 4, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Recurrent Acute Myeloid Leukemia Trial in Houston (Decitabine and

    Recruiting
    • Acute Myeloid Leukemia
    • +3 more
    • Decitabine and Cedazuridine
    • +2 more
    • Houston, Texas
      M D Anderson Cancer Center
    Apr 19, 2022

    Related Donors Donating PBSC to a Family Member, Healthy Donors, Acute Myelogenous Leukemia Trial in United States (MGTA-145,

    Terminated
    • Related Donors Donating PBSC to a Family Member
    • +4 more
    • MGTA-145
    • Plerixafor
    • Duarte, California
    • +7 more
    Apr 13, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Duarte, New York, Houston (BTX-A51)

    Recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Duarte, California
    • +2 more
    Apr 18, 2022

    Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Leukemia in Remission, Acute Lymphoblastic Leukemia

    Recruiting
    • Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
    • +36 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Apr 5, 2022

    Myelodysplastic Syndrome Trial (RBC transfusion)

    Not yet recruiting
    • Myelodysplastic Syndrome
    • RBC transfusion
    • (no location specified)
    Apr 5, 2022

    Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in Germany, United States (Emavusertib, Azacitidine, Venetoclax)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Myelodysplastic Syndrome
    • Tampa, Florida
    • +8 more
    Apr 5, 2022

    Acute Lymphoblastic Leukemia, Acute Myelogenous Leukemia, Myelodysplastic Syndrome Trial in New Hyde Park (radiation, drug,

    Completed
    • Acute Lymphoblastic Leukemia
    • +5 more
    • Radiation
    • +3 more
    • New Hyde Park, New York
      Cohen Children's Medical Center
    Apr 6, 2022